NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women

Completed

Conditions: HIV Infections
Pregnancy

First Posted Date: 2001-08-31

Last Posted Date: 2006-08-07

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 160

Registration Number: NCT00017797

Locations: 🇺🇸
The CORE Ctr, Chicago, Illinois, United States
🇺🇸
Univ of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
Univ of Miami (Pediatric), Miami, Florida, United States

and more 37 locations

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

Phase 1

Completed

Conditions: HIV Infections
HIV Seronegativity
Lipodystrophy

First Posted Date: 2001-08-31

Last Posted Date: 2006-03-14

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 56

Registration Number: NCT00017758

Locations: 🇺🇸
Univ of Colorado Health Sciences Ctr, Denver, Colorado, United States
🇺🇸
Univ of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Washington Univ School of Medicine, St Louis, Missouri, United States

and more 7 locations

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 18

Registration Number: NCT00000663

Locations: 🇺🇸
Texas Children's Hosp / Baylor Univ, Houston, Texas, United States
🇺🇸
Cook County Hosp, Chicago, Illinois, United States
🇺🇸
UCSD Treatment Ctr, San Diego, California, United States

and more 4 locations

Intracellular Pharmacokinetics of Zidovudine Triphosphate in Maternal and Infant Cord Blood Mononuclear Cells.

Completed

Conditions: HIV Infections
Pregnancy

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 24

Registration Number: NCT00000830

Locations: 🇺🇸
Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark, New Jersey, United States
🇺🇸
Bellevue Hosp / New York Univ Med Ctr, New York, New York, United States
🇺🇸
Mount Sinai Med Ctr / Pediatrics, New York, New York, United States

and more 3 locations

Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2005-06-24

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 350

Registration Number: NCT00000858

Locations: 🇺🇸
Univ of California / San Francisco, San Francisco, California, United States
🇺🇸
Georgetown Univ Med Ctr, Washington, District of Columbia, United States
🇺🇸
SUNY / Health Sciences Ctr at Brooklyn, Brooklyn, New York, United States

Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2010-04-26

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 120

Registration Number: NCT00001097

Locations: 🇺🇸
Univ of Illinois College of Medicine / Pediatrics, Chicago, Illinois, United States
🇺🇸
Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, United States
🇺🇸
Connecticut Children's Med Ctr, Farmington, Connecticut, United States

and more 43 locations

Observing Patients With Early HIV Infection

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2010-03-25

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 10

Registration Number: NCT00005020

Locations: 🇺🇸
Joanne Santangelo, San Diego, California, United States

Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)

Phase 1

Completed

Conditions: Papilloma

First Posted Date: 2001-08-31

Last Posted Date: 2010-08-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 36

Registration Number: NCT00001126

Locations: 🇺🇸
NIAID/DMID/CASG Central Unit, Birmingham, Alabama, United States

A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia

Completed

Conditions: Neutropenia

First Posted Date: 2001-08-31

Last Posted Date: 2010-08-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 866

Registration Number: NCT00008840

Locations: 🇺🇸
Mary Ellen Bradley, Birmingham, Alabama, United States

Study of a Flu Vaccine in Children

Phase 3

Completed

Conditions: Influenza

First Posted Date: 2001-08-31

Last Posted Date: 2010-08-27

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 15000

Registration Number: NCT00001127

Locations: 🇺🇸
Pedro A. Piedra, M.D., Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy